Symbols / VIVE
VIVE Chart
About
Viveve develops and sells healthcare-focused human resources (HR) software solutions designed to streamline and unify HR operations for healthcare organizations. It offers an all-in-one platform that supports recruitment, employee management, and attendance management, aiming to reduce administrative burden and enhance the employee experience throughout their career lifecycle. The company also provides solutions specifically tailored for the healthcare and mental and behavioral health sectors. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 3.22K |
| Enterprise Value | 110.22K | Income | -28.14M | Sales | 6.83M |
| Book/sh | 0.11 | Cash/sh | 0.55 | Dividend Yield | — |
| Payout | 0.00% | Employees | 47 | IPO | — |
| P/E | — | Forward P/E | -0.00 | PEG | — |
| P/S | 0.00 | P/B | 0.00 | P/C | — |
| EV/EBITDA | -0.01 | EV/Sales | 0.02 | Quick Ratio | 0.62 |
| Current Ratio | 0.89 | Debt/Eq | 507.94 | LT Debt/Eq | — |
| EPS (ttm) | -1.99 | EPS next Y | -1.60 | EPS Growth | — |
| Revenue Growth | 4.20% | Earnings | 2022-11-10 16:00 | ROA | -62.13% |
| ROE | -210.99% | ROIC | — | Gross Margin | 16.39% |
| Oper. Margin | -276.84% | Profit Margin | 0.00% | Shs Outstand | 10.72M |
| Shs Float | 10.72M | Short Float | 3.49% | Short Ratio | 4.15 |
| Short Interest | — | 52W High | 0.02 | 52W Low | 0.00 |
| Beta | -56.22 | Avg Volume | 1.89K | Volume | 2.33K |
| Target Price | — | Recom | None | Prev Close | $0.00 |
| Price | $0.00 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-12.71
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
- NYSE Content Update: Stock Market to Open Like Normal Amid Historic NYC Blizzard - Yahoo Finance Mon, 23 Feb 2026 13
- Health plans detail opportunities, pitfalls of AI at ViVE - Modern Healthcare News Mon, 23 Feb 2026 19
- Walk inside The Little Prince: new 45-minute VR adventure opens in Japan - Stock Titan Wed, 18 Feb 2026 14
- Remedy Meds Acquires Thirty Madison in All-Stock Deal Valued at over $500M - HLTH Mon, 08 Sep 2025 07
- PROG Holdings Announces Sale of Vive Credit Card Receivables Portfolio to Atlanticus - Business Wire Wed, 22 Oct 2025 07
- HTC shares soar for 2nd straight session after Vive Eagle AI glasses debut - Focus Taiwan Mon, 18 Aug 2025 07
- PROG: Buy Now, Pay Later Segment May Power P/E Rerate. (NYSE:PRG) - Seeking Alpha hu, 27 Nov 2025 08
- Healthcare’s hidden ‘dark data’: how eFax turns faxes and scans into AI-ready data - Stock Titan hu, 12 Feb 2026 08
- Vive la nouvelle architecture! India, France deepen ties with 21-point roadmap on defence, AI, minerals an - The Economic Times Wed, 18 Feb 2026 17
- PROG Holdings Sells Vive Receivables for $150 Million - TipRanks Wed, 22 Oct 2025 07
- PROG Holdings Reports Third Quarter 2025 Results - Business Wire Wed, 22 Oct 2025 07
- Azioni Reddit: Si vive una volta sola - TradingView ue, 09 Dec 2025 08
- Vive La France? Stocks Off to a Flier in 2023 | Morningstar UK - Morningstar Canada ue, 10 Jan 2023 08
- Taiwan stock market volatile but hits near-record highs - Taiwan News Fri, 15 Aug 2025 07
- Tampa General Hospital CEO shares advice on planning for weather emergencies | ViVE 2025 - Chief Healthcare Executive ue, 18 Feb 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2021-12-31 |
|---|---|
| TaxEffectOfUnusualItems | 0.00 |
| TaxRateForCalcs | 0.00 |
| NormalizedEBITDA | -20.62M |
| TotalUnusualItems | 985.00K |
| TotalUnusualItemsExcludingGoodwill | 985.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -22.03M |
| ReconciledDepreciation | 1.14M |
| ReconciledCostOfRevenue | 5.81M |
| EBITDA | -19.63M |
| EBIT | -20.77M |
| NetInterestIncome | -1.00M |
| InterestExpense | 1.00M |
| NormalizedIncome | -23.01M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -22.03M |
| TotalExpenses | 27.98M |
| TotalOperatingIncomeAsReported | -21.55M |
| DilutedAverageShares | 10.09M |
| BasicAverageShares | 10.09M |
| DilutedEPS | -2.65 |
| BasicEPS | -2.65 |
| DilutedNIAvailtoComStockholders | -26.72M |
| NetIncomeCommonStockholders | -26.72M |
| PreferredStockDividends | 4.69M |
| NetIncome | -22.03M |
| MinorityInterests | -256.00K |
| NetIncomeIncludingNoncontrollingInterests | -22.03M |
| NetIncomeContinuousOperations | -22.03M |
| EarningsFromEquityInterestNetOfTax | -256.00K |
| PretaxIncome | -21.77M |
| OtherIncomeExpense | 782.00K |
| OtherNonOperatingIncomeExpenses | -203.00K |
| SpecialIncomeCharges | 1.36M |
| OtherSpecialCharges | -1.36M |
| GainOnSaleOfSecurity | -373.00K |
| NetNonOperatingInterestIncomeExpense | -1.00M |
| InterestExpenseNonOperating | 1.00M |
| OperatingIncome | -21.55M |
| OperatingExpense | 22.17M |
| ResearchAndDevelopment | 9.66M |
| SellingGeneralAndAdministration | 12.51M |
| GrossProfit | 620.00K |
| CostOfRevenue | 5.81M |
| TotalRevenue | 6.43M |
| OperatingRevenue | 6.43M |
| Line Item | 2021-12-31 |
|---|---|
| OrdinarySharesNumber | 10.62M |
| ShareIssued | 10.62M |
| TotalDebt | 5.35M |
| TangibleBookValue | 15.07M |
| InvestedCapital | 20.19M |
| WorkingCapital | 17.70M |
| NetTangibleAssets | 15.07M |
| CapitalLeaseObligations | 225.00K |
| CommonStockEquity | 15.07M |
| TotalCapitalization | 20.19M |
| TotalEquityGrossMinorityInterest | 15.07M |
| StockholdersEquity | 15.07M |
| RetainedEarnings | -241.85M |
| AdditionalPaidInCapital | 256.92M |
| CapitalStock | 1.00K |
| CommonStock | 1.00K |
| TotalLiabilitiesNetMinorityInterest | 10.85M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 6.31M |
| OtherNonCurrentLiabilities | 1.19M |
| LongTermDebtAndCapitalLeaseObligation | 5.12M |
| LongTermDebt | 5.12M |
| CurrentLiabilities | 4.53M |
| CurrentDeferredLiabilities | 448.00K |
| CurrentDeferredRevenue | 448.00K |
| CurrentDebtAndCapitalLeaseObligation | 225.00K |
| CurrentCapitalLeaseObligation | 225.00K |
| PayablesAndAccruedExpenses | 3.86M |
| CurrentAccruedExpenses | 2.38M |
| Payables | 1.48M |
| AccountsPayable | 1.48M |
| TotalAssets | 25.91M |
| TotalNonCurrentAssets | 3.67M |
| OtherNonCurrentAssets | 1.54M |
| InvestmentsAndAdvances | 577.00K |
| LongTermEquityInvestment | 577.00K |
| InvestmentsInOtherVenturesUnderEquityMethod | 577.00K |
| NetPPE | 1.55M |
| AccumulatedDepreciation | -2.75M |
| GrossPPE | 4.30M |
| Leases | 122.00K |
| OtherProperties | 3.75M |
| MachineryFurnitureEquipment | 436.00K |
| Properties | 0.00 |
| CurrentAssets | 22.24M |
| PrepaidAssets | 1.05M |
| Inventory | 1.47M |
| FinishedGoods | 979.00K |
| RawMaterials | 493.00K |
| Receivables | 549.00K |
| AccountsReceivable | 549.00K |
| AllowanceForDoubtfulAccountsReceivable | -66.00K |
| GrossAccountsReceivable | 615.00K |
| CashCashEquivalentsAndShortTermInvestments | 19.16M |
| CashAndCashEquivalents | 19.16M |
| Line Item | 2021-12-31 |
|---|---|
| FreeCashFlow | -13.33M |
| IssuanceOfDebt | 0.00 |
| IssuanceOfCapitalStock | 25.83M |
| CapitalExpenditure | -456.00K |
| InterestPaidSupplementalData | 0.00 |
| IncomeTaxPaidSupplementalData | 0.00 |
| EndCashPosition | 19.16M |
| BeginningCashPosition | 6.52M |
| ChangesInCash | 12.64M |
| FinancingCashFlow | 25.97M |
| CashFlowFromContinuingFinancingActivities | 25.97M |
| NetOtherFinancingCharges | -70.00K |
| ProceedsFromStockOptionExercised | 217.00K |
| NetCommonStockIssuance | 25.83M |
| CommonStockIssuance | 25.83M |
| NetIssuancePaymentsOfDebt | 0.00 |
| NetLongTermDebtIssuance | 0.00 |
| LongTermDebtIssuance | 0.00 |
| InvestingCashFlow | -456.00K |
| CashFlowFromContinuingInvestingActivities | -456.00K |
| NetPPEPurchaseAndSale | -456.00K |
| PurchaseOfPPE | -456.00K |
| OperatingCashFlow | -12.88M |
| CashFlowFromContinuingOperatingActivities | -12.88M |
| ChangeInWorkingCapital | 4.12M |
| ChangeInOtherCurrentLiabilities | 365.00K |
| ChangeInOtherCurrentAssets | 320.00K |
| ChangeInPayablesAndAccruedExpense | 1.15M |
| ChangeInAccruedExpense | 553.00K |
| ChangeInPayable | 599.00K |
| ChangeInAccountPayable | 599.00K |
| ChangeInPrepaidAssets | -24.00K |
| ChangeInInventory | 2.21M |
| ChangeInReceivables | 96.00K |
| ChangesInAccountReceivables | 96.00K |
| OtherNonCashItems | 862.00K |
| StockBasedCompensation | 3.78M |
| ProvisionandWriteOffofAssets | 125.00K |
| DepreciationAmortizationDepletion | 1.14M |
| DepreciationAndAmortization | 1.14M |
| Depreciation | 1.14M |
| OperatingGainsLosses | -872.00K |
| GainLossOnInvestmentSecurities | 373.00K |
| GainLossOnSaleOfPPE | 113.00K |
| NetIncomeFromContinuingOperations | -22.03M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for VIVE
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|